Literature DB >> 10334481

Expression of transforming growth factor-beta1, 2, 3 isoforms and type I and II receptors in acute focal cerebral ischemia: an immunohistochemical study in rat after transient and permanent occlusion of middle cerebral artery.

K A Ata1, F Lennmyr, K Funa, Y Olsson, A Terént.   

Abstract

Transforming growth factor beta (TGF-beta) is involved in the modulation of cell growth, differentiation and repair following injury of various organs. Previous studies on human autopsy material have indicated that TGF-beta isoforms-beta1, -beta2 and -beta3, and TGF-beta receptor type I are expressed in various cells of necrotizing brain lesions like infarction and abscess. The present immunohistochemical study was designed to investigate changes that may occur with regard to TGF-beta and its receptors type I and II in a rat model of focal brain ischemia induced by transient or permanent occlusion of the middle cerebral artery. Our findings indicate that at days 1 and 3 following such transient and permanent ischemia there is an up-regulation of TGF-beta isoforms -beta1, -beta2 and -beta3, and TGF-beta receptor types I and II mainly in the perifocal neurons, reactive astroglial cells, endothelial cells and macrophages.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334481     DOI: 10.1007/s004010051013

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  10 in total

1.  Proof of concept: endogenous antiangiogenic factors predict the occurrence of symptomatic vasospasm post subarachnoid hemorrhage.

Authors:  Fernando D Testai; Venkatesh Aiyagari; Maureen Hillmann; Sepideh Amin-Hanjani; Glyn Dawson; Philip Gorelick
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

2.  Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain.

Authors:  Patrick T Ronaldson; Kristin M Demarco; Lucy Sanchez-Covarrubias; Christine M Solinsky; Thomas P Davis
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-25       Impact factor: 6.200

3.  Trefoil factor 3 as an endocrine neuroprotective factor from the liver in experimental cerebral ischemia/reperfusion injury.

Authors:  Shu Q Liu; Derek Roberts; Brian Zhang; Yupeng Ren; Li-Qun Zhang; Yu H Wu
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

4.  Blood-brain barrier dysfunction in epileptogenesis of the temporal lobe.

Authors:  Itai Weissberg; Aljoscha Reichert; Uwe Heinemann; Alon Friedman
Journal:  Epilepsy Res Treat       Date:  2011-06-07

5.  TGF-β1 protection against Aβ1-42-induced neuroinflammation and neurodegeneration in rats.

Authors:  Wei-Xing Shen; Jia-Hui Chen; Jian-Hua Lu; Yu-Ping Peng; Yi-Hua Qiu
Journal:  Int J Mol Sci       Date:  2014-12-01       Impact factor: 5.923

6.  Hypoxia-induced activin A diminishes endothelial cell vasculogenic activity.

Authors:  Stephanie Merfeld-Clauss; Hongyan Lu; Xue Wu; Keith L March; Dmitry O Traktuev
Journal:  J Cell Mol Med       Date:  2017-08-18       Impact factor: 5.310

7.  TGFβ1 Induces Axonal Outgrowth via ALK5/PKA/SMURF1-Mediated Degradation of RhoA and Stabilization of PAR6.

Authors:  Julia Kaiser; Martina Maibach; Ester Piovesana; Iris Salpeter; Nora Escher; Yannick Ormen; Martin E Schwab
Journal:  eNeuro       Date:  2020-09-29

8.  The neuroprotective functions of transforming growth factor beta proteins.

Authors:  Arpád Dobolyi; Csilla Vincze; Gabriella Pál; Gábor Lovas
Journal:  Int J Mol Sci       Date:  2012-07-03       Impact factor: 6.208

9.  Using a novel in vivo model to study the function of nuclear factor kappa B in cerebral ischemic injury.

Authors:  Rui Wang; Songlan Liang; Hui Yue; Lijie Chen
Journal:  Med Sci Monit       Date:  2012-11

10.  Induction of transforming growth factor beta receptors following focal ischemia in the rat brain.

Authors:  Gabriella Pál; Gábor Lovas; Arpád Dobolyi
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.